Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | XBP1 | P17861 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24824267 | 0.79 | HTT (0.42) | LMNANPSR1HPGDXBP1SMN1; SMN2 | |
| SCHEMBL20227110 | 0.78 | USP2 (0.41) | LMNANPSR1HPGDXBP1SMN1; SMN2 | |
| SCHEMBL28344591 | 0.77 | — | — | |
| SCHEMBL22394151 | 0.77 | LMNA (0.32) | LMNANPSR1HPGDXBP1SMN1; SMN2 | |
| SCHEMBL17925010 | 0.76 | HSD17B10 (0.33) | HTT | |
| SCHEMBL26327571 | 0.75 | — | — | |
| SCHEMBL859268 | 0.74 | — | — | |
| SCHEMBL4429611 | 0.73 | — | — | |
| SCHEMBL6973523 | 0.73 | LMNA (0.36) | LMNANPSR1HPGDXBP1SMN1; SMN2 | |
| SCHEMBL5350628 | 0.73 | LMNA (0.36) | LMNANPSR1HPGDXBP1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130269568-A1 | DERIVATIVES FOR PERFLUOROALKOXY SULFOSUCCINATES AS SURFACTANTS | MERCK PATENT GMBH (DE) | 2013-10-17 | — | — | US | disclosed |
| US-20130269568-A1 | DERIVATIVES FOR PERFLUOROALKOXY SULFOSUCCINATES AS SURFACTANTS | MERCK PATENT GMBH (DE) | 2013-10-17 | — | — | US | disclosed |
| US-20130269568-A1 | DERIVATIVES FOR PERFLUOROALKOXY SULFOSUCCINATES AS SURFACTANTS | MERCK PATENT GMBH (DE) | 2013-10-17 | — | — | US | disclosed |
| WO-2012084118-A1 | DERIVATIVES OF PERFLUOROALKOXY SULFOSUCCINATES AS SURFACE-ACTIVE SURFACTANTS | MERCK PATENT GMBH (DE) | 2012-06-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130269568-A1 | DERIVATIVES FOR PERFLUOROALKOXY SULFOSUCCINATES AS SURFACTANTS | PFAS, SFXN3, FGB | LMNA 2574/4885NPSR1 168/4885HPGD 3623/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.